Clinical Trial Update: Hypotension Prediction Index (HPI) SMART-BP Trial [NA]

View source ↗

Summary

Clinical trial update indicating termination of the Hypotension Prediction Index (HPI) SMART-BP trial in moderate to high-risk noncardiac surgery; results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• To High-risk Noncardiac Surgery

Drugs mentioned

• Hypotension Prediction Index (HPI) SMART-BP trial

Snippet

Sponsor: Edwards Lifesciences | Conditions: Moderate to High-risk Noncardiac Surgery | NA | Status: TERMINATED | Results posted: 2024-03-25